药物总览提供了葡萄糖氯己定Chlorhexidine gluconate相关药品信息, 涵盖了药品临床前,临床阶段,注册,上市等药品全生命周期研发数据, 通过表格与图表等形式多维度地帮助帮助用户筛选与查看
Generic name:chlorhexidine gluconate (oral rinse) [klor-HEX-i-deen] Brand names:Peridex,PerioChip,Periogard Dosage forms:mucous membrane insert (2.5 mg), mucous membrane liquid (0.12%) Drug classes:Antiseptic and germicides,Mouth and throat products ...
Drug class: antiseptic and germicides Breastfeeding Patient resources Chlorhexidine gluconate oral rinse drug information Chlorhexidine (Periodontal) (Advanced Reading) Chlorhexidine Gluconate (Oral) Chlorhexidine Gluconate (Topical) Other brands Peridex, Hibiclens, Periogard, Betasept, ... +11 more Profess...
药品名称:CHLORHEXIDINE GLUCONATE,活性成分:CHLORHEXIDINE GLUCONATE,剂型:SOLUTION;DENTAL,规格:0.12%,药品注册申请号:075006,产品号:001
美国FDA提供产品Chlorhexidine Gluconate申请号071419的药品信息, 包括商品名,活性成分,申请机构,剂型,规格,新报申请信息,补充申请信息及071419橙皮书信息.
葡萄糖酸氯己定软膏药品报告提供了葡萄糖酸氯己定软膏的各种信息,包括葡萄糖酸氯己定软膏的药品简介,新药研发进度,仿制药申报进度,中国药品注册情况,一致性评价进度,药品临床试验进度,药品上市等信息.更多药物报告的查询就在戊戌数据药物报告数据库.
1 药品名称 CHLORHEXIDINE GLUCONATE 申请号 019490 产品号 001 活性成分 CHLORHEXIDINE GLUCONATE 市场状态 停止上市 剂型或给药途径 SPONGE;TOPICAL 规格 4% 治疗等效代码 参比药物 否 批准日期 1987/03/27 申请机构 KENDALL CO 2 药品名称 CHLORHEXIDINE GLUCONATE 申请号 021669 产品号 001 活性成分 CHLORHEXIDINE ...
Generic Name(S):chlorhexidine gluconate Uses Thismedicationis used along with regulartoothbrushing/flossing to treatgingivitis, agum diseasethat causes red, swollen, and easilybleeding gums. Chlorhexidine belongs to a class of drugs known as antimicrobials. It works by decreasing the amount of bacteria...
In aqueous solution, chlorhexidine salts may undergo hydrolysis to form 4-chloroaniline, catalyzed by heating and an alkaline pH. Following autoclaving of a 0.02% w/v chlorhexidine gluconate solution at pH 9 for 30 minutes at 1208℃, it was found that 1.56% w/w of the original chlorhexidine ...
The Approved Drug Products with Therapeutic Equivalence Evaluations List identifies currently marketed prescription and over-the-counter drug products, incl chlorhexidine gluconate, approved on the basis of safety and effectiveness by FDA under sections 505 of the Federal Food, Drug, and Cosmetic Act. ...